Item 8.01. Other Events.

On July 22, 2021, Acorda Therapeutics, Inc. (the "Company") issued a press release announcing that it has entered into distribution and supply agreements with Esteve Pharmaceuticals S.A to commercialize INBRIJA 33 mg (levodopa inhalation powder, hard capsules) in Spain. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K, and is incorporated by reference into this Item 8.01.

Item 9.01. Financial Statements and Exhibits.





(d) Exhibits



Exhibit No.   Description
99.1            Press Release dated July 22, 2021
104           Cover Page Interactive Data File (formatted as inline XBRL and
              contained in Exhibit 101)

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses